Varicella zoster virus — Drug Target
All drugs that target Varicella zoster virus — marketed and clinical-stage. Includes 2 drug classes acting on this target.
Drug classes
Vaccine · Live attenuated vaccine
Marketed (4)
- Shingrix · GSK · Vaccine · Immunology
- varicella-3 · Beijing Center for Disease Control and Prevention · Live attenuated vaccine · Immunology / Infectious Disease
Varicella-3 is a live attenuated varicella-zoster virus vaccine that stimulates immune responses to prevent chickenpox infection. - varicella-5 · Changchun Keygen Biological Products Co., Ltd. · Live attenuated vaccine · Immunology / Infectious Disease
Varicella-5 is a live attenuated varicella-zoster virus vaccine that stimulates immune responses to prevent chickenpox infection. - varicella-6 · Beijing Center for Disease Control and Prevention · Live attenuated vaccine · Immunology / Infectious Disease
Varicella-6 is a live attenuated varicella-zoster virus vaccine that stimulates immune responses to prevent varicella (chickenpox) infection.
Phase 3 pipeline (1)
- Comparator: Varicella Zoster Virus Vaccine · Merck Sharp & Dohme LLC · Live attenuated vaccine · Immunology / Infectious Disease
This vaccine stimulates the immune system to produce antibodies and cellular immunity against varicella zoster virus, preventing chickenpox and herpes zoster infection.